Blow Fill Seal (BFS) Technology Market

Blow Fill Seal (BFS) Technology Market: Growing Need for Attaining High Manufacturing Efficiency in Packaging to Trigger Promising Investment Opportunities: Global Industry Analysis and Opportunity

Blow Fill Seal (BFS) Technology Market- Key Research Findings

According to Future Market Insights’ latest market report titled “Blow Fill Seal Technology Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029”, the global blow fill seal technology market is estimated to be valued at ~US$ 2 Bn in 2019, and grow at a CAGR of ~ 8% during the forecast period. The study also opines that consumer awareness for unit dose packaging and demand for aseptic filling will remain the driving engines for the blow fill seal technology market. 

Blow Fill Seal (BFS) Technology Market Outlook

The blow fill seal technology, also known as BFS technology, is receiving immense popularity in the pharmaceutical industries. One of the prominent use of BFS technology is to reduce the contamination through the formation of container, filling, and sealing in the sterile chamber. Since the process is indeed an exhaustive process with no personal intervention, the blow fill seal technology offers productional at low overhead costs and high reliance on sterility.

Besides this, manufacturers in the BFS technology market have been investing in advanced aseptic manufacturing technologies for filling of liquid medicines. Among the other pharmaceuticals, application of the blow fill seal technology for filling small containers for respiratory and ophthalmic drug ampoules. Since the pollution level has been increasing, there has been a rise in asthmatic patients and individuals suffering from respiratory disorders.

Yet another crucial application of blow fill seal technology is for biologics, which is expected to contribute to the growth of the BFS technology market during the forecast period. Besides this, there have been advancements in the BFS technology that enables packaging of containers such as vials, electrolyte bottles, pre-filled injectables, eyewash and contact lens bottles, and more.

Several opportunities lay ahead for the blow fill seal technology market players in the form of automation and rise in the number of packaging per minute. On similar lines, in May 2017, Weiler Engineering signed an agreement with Noxilier for strengthening the portfolio. In addition, in July 2016, Curida and PCI Biotech entered into an agreement for catering to the demand for blow fill seal technology. However, high investment required for the incorporation of the blow fill seal technology could seem unattractive to the small and medium pharmaceutical companies, and, in turn, reduce the revenue potential of the market.

Key Factors Shaping the Global Blow Fill Seal (BFS) Technology Market

  • Increasing Need for Aseptic Filling Technology in Drug Packaging Industry

    Safety and quality are the most important factors in drug or pharmaceutical packaging. The blow fill seal technology is beneficial for filling ophthalmic, injectable vaccines and biologic drugs. These drugs can be filled in various packaging formats such as vials, ampoules and bottles which can be made up of glass or plastic. In order to fill aseptic liquid drugs and allow their safe and easy administration, blow fill seal technology is preferred, and this will continue to foster growth of the global market.

  • Surging Demand for Unit Dose Packaging Solutions for Injectable & Ophthalmic Drugs

    As per global standards of aseptic packaging, the blow fill seal technology is adopted during the packaging of injectable and ophthalmic drugs. Aseptic packaging technology is also gaining traction as it eliminates the need for preservatives, thereby minimizing the risk of allergic reactions among the patients.

    The adoption of blow fill seal technology in the injectable products is estimated to account for more than 1/3rd of the global market, and its need in respiratory therapies is expected grow in the coming years. The penetration of blow fill seal technology has witnessed an increase, as use of this technology enables precise drug withdrawal without the need of syringes. 

  • Global Blow Fill Seal (BFS) Technology: Regional Analysis

    North America is estimated to dominate the blow fill seal technology market and account for more than 43% during the forecast period. In North America, pharmaceutical companies are extensively adopting blow fill seal technology to facilitate their need for unit-dose packaging. Moreover, in this region, the adoption of the technology in injectable and ophthalmic products cumulatively accounted for nearly half the revenue share of the blow fill seal technology market, creating an incremental opportunity of ~690 Mn during the forecast period.

    Western Europe and North America are anticipated to be prominent markets for blow fill seal technology as these regions house key drug manufacturers. However, these manufacturers are using advanced aseptic technology which is further expected to increase the demand for blow fill seal technology in the pharmaceutical sector.

    North America is projected to expand the highest CAGR in the global blow fill seal technology market during the forecast period. Latin America, APEJ and MEA have relatively lower penetration of blow fill seal technology. However, the adoption is expected to increase substantially with the growing demand for superior pharmaceutical packaging solutions in the region.

Global Blow Fill Seal (BFS) Technology Market: Structure Analysis

Unither Pharmaceuticals, Inc., Unipharma, LLC, The Ritedose Corporation, and Catalent Inc. have been identified as the tier 1 players operating in the global blow fill seal technology market. These players are strategically expanding their geographic reach, to strengthen their foothold in the global market. For instance,

  • Catalent Inc. acquired Juniper pharmaceutical Inc. in 2018, this acquisition is expected to strengthen Catalent’s offerings in formulation development, and clinical-scale oral dose manufacturing.
  • In 2018, Curida AS, completed the acquisition of the Norwegian pharmaceutical manufacturer As produksjonslab. With this acquisition, the company aims to strengthen its position as a Contract Development and Manufacturing Organization (CDMO) in the competitive pharmaceutical market.

However, several other blow fill seal technology players are emerging as prominent regional players such as Horizon Pharmaceutical, Inc. Takeda Pharmaceuticals International AG, Sentiss LLC and others. These players are likely to make the market more competitive by impacting regional pricing trends.

Blow Fill Seal (BFS) Technology Market: Key Developments

Several pharmaceutical packaging companies are expanding their manufacturing of blow fill seal technology machinery units. Furthermore, these companies are expanding their geographic reach to cater to the increasing demand from developing countries. For instance,

  • In March 2018 Recipharm, a Sweden based contract development and manufacturing organization has installed a new blow fill seal technology machine at its facility in Kaysersberg, France.
  • In April, 2019 Unicep Packaging LLC, a liquid filling and packaging company, announced the expansion of their services to include refined custom design and quick turn prototype capabilities. These services will be available with Unicep’s single-use modified blow fill seal technology product line.

Blow Fill Seal (BFS) Technology Market - Report Scope



Forecast Period


Historical Data Available for


Market Analysis

US$ Mn for Value and Volume

Key Regions Covered

North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa (MEA)

Key Countries Covered

U.S, Canada, Germany, Brazil, Mexico, Rest of Latin America, U.K., France, Italy, Spain, Rest of Europe, Nordic, BENELUX, Rest of Western Europe, Russia, Poland, Rest of Easterm Europe, ASEAN, Japan, India, China, South Korea, Rest of Asia Pacific excluding Japan, Australia, New Zealand, GCC, North Africa, South Africa, Rest of MEA

Key Segments Covered

Product, Material, End Use, Region

Key Companies Profiled

  • Unither Pharmaceuticals
  • Rommelag
  • Catalent, Inc.
  • Curida AS
  • Unipharma LLC
  • Weiler Engineering, Inc.
  • GlaxoSmithKline plc
  • Takeda Pharmaceuticals International AG
  • Nephron Pharmaceuticals Corporation
  • Horizon Pharmaceuticals, Inc.
  • Brevetti Angela S.R.L.
  • Recipharm AB, SIFI S.p.A
  • Laboratorios SALVAT, S.A.
  • The Ritedose Corporation
  • Unicep Packaging, LLC
  • Pharmapack Co. Ltd.
  • Amanta Healthcare Ltd
  • Automatic Liquid Packaging Solutions LLc
  • Asept Pak, Inc.

Report Coverage

Market Overview, Key Market Trends, Key Success Factors, Demand Analysis, Market Background, COVID-19 Analysis, Segmental Analysis, Regional Profiling, Market Structure & Competition Analysis

Customization & Pricing

Available Upon Request

Key Segment

By Product

  • Bottles
    • 0.2-100ml
    • 100-500ml
    • Above 500ml
  • Ampoules
    • 0.1-10ml
    • 10-100ml
  • Vials
    • 0.1-10ml
    • 10-50ml
    • Others

By Material

  • PE
    • LDPE
    • HDPE
  • PP
  • Others

By End-use Industry

  • Pharmaceuticals
    • Ophthalmic
    • Injectable
    • Biologics
    • Wound Care
    • Respiratory
  • Food & Beverages
  • Cosmetics & Personal Care
  • Others

By Region

  • North America
  • Latin America
  • APEJ
  • Western Europe
  • Eastern Europe
  • Middle East & Africa
  • Japan

Need specific information?

In the news

How Businesses Can Utilize Market Research to Create Reactive, Recession-proof Strategies for Survival

by - Sudip Saha, Managing Director and Co-Founder of Future Market Insights

Our Clients

View Our Reports from Packaging

View Reports


Blow Fill Seal (BFS) Technology Market